Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

2.1K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

692
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.1K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

36
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatologic immune-related adverse events associated with immune checkpoint inhibitors: A prospective real-world observational study in Switzerland.

JAAD international·2026
Same author

Outcome and long-term treatment protocol for topical tacrolimus in oral lichen planus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

New onset of sarcoidosis after COVID-19 infection.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

A relapsing localized variant of neutrophilic dermatosis triggered by tissue injury.

The British journal of dermatology·2020

Related Experiment Video

Updated: Apr 30, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.4K

[The dermocorticoids, irreplaceable and feared].

C Zenklusen, L Feldmeyer

    Revue Medicale Suisse
    |May 6, 2014
    PubMed
    Summary

    Dermocorticoids are vital for inflammatory skin conditions, offering anti-inflammatory benefits. While skin side effects are often overestimated, systemic effects require careful consideration and adherence to safety guidelines.

    Area of Science:

    • Dermatology
    • Pharmacology

    Context:

    • Dermocorticoids are widely used for inflammatory dermatoses.
    • Their therapeutic benefits stem from anti-inflammatory and anti-proliferative actions.

    Purpose:

    • To review the properties of dermocorticoids.
    • To outline guidelines for minimizing adverse reactions, both cutaneous and systemic.

    Summary:

    • Dermocorticoids are essential in dermatology for treating inflammatory skin diseases.
    • Cutaneous side effects are frequently overestimated, whereas systemic adverse effects are less understood.
    • This review details dermocorticoid properties and crucial safety rules.

    Impact:

    • Enhances understanding of dermocorticoid risks and benefits.

    More Related Videos

    Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
    11:06

    Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

    Published on: November 11, 2022

    2.9K
    Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
    06:30

    Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

    Published on: May 23, 2025

    1.1K

    Related Experiment Videos

    Last Updated: Apr 30, 2026

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    38.4K
    Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
    11:06

    Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

    Published on: November 11, 2022

    2.9K
    Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
    06:30

    Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

    Published on: May 23, 2025

    1.1K
  • Promotes safer prescribing practices in dermatology.
  • Aims to reduce the incidence of adverse events associated with dermocorticoid use.